Release date: 2024-08-19 17:12:09 Article From: Lucius Laos Recommended: 107
Anamoreline is the world's first drug for the treatment of cancer cachexia, which was launched in Japan in 2021; By activating ghrelin receptors, it increases appetite and promotes muscle growth, helping patients improve their nutritional status. As the only drug of its kind, anamarin has shown remarkable results in improving the quality of life of cancer patients.
There are several versions of Anamorelin, including the 50mg 100 tablets produced by Lucius Laos, which is priced at about 3,000 yuan per box; Another version is a 50mg 100 capsule package launched by the Adlumiz brand, about 4300 yuan a box, providing a 50-day supply. These versions vary in price and brand, and patients can choose the right version according to their needs.
Anamoreline, as a key therapeutic drug, needs to be used under the guidance of a medical professional. Each patient's health and condition is different, and the doctor will develop a personalized treatment plan according to the specific situation, and the patient should strictly follow the doctor's advice when taking the medication.
Special attention needs to be paid to the use of drugs by special populations, and their specific circumstances may require adjustments to the dose, frequency, or mode of use of the drug to better meet their actual needs.
There are currently no data from clinical studies in children, and self-use of the drug is not recommended for children. Children's medication should be given under strict guidance from a doctor to ensure that the medication is appropriate for their specific needs and health conditions.
Caution should be exercised when using the drug in older people. Older people may experience a natural decline in physiological functions, such as kidney function, liver function, and immune function, which may affect the metabolism and effectiveness of medications. It is necessary to closely observe the changes in the condition of elderly patients and adjust the medication regimen according to the actual situation.
There are several important considerations to pay special attention to when using this drug:
Anamorelin has sodium channel inhibition and may cause ECG abnormalities such as PR interval, QRS interval, or QT prolongation. ECG, pulse, blood pressure, and electrolyte levels should be checked regularly before and during use. If any abnormalities are found, the medication should be stopped immediately.
Blood glucose levels should be measured regularly before and during the use of anamorline to avoid hyperglycemia.
[Warm tips] If you have diabetes or have used anthracyclines, please monitor your blood sugar level closely when using Anamorelin, inform your doctor of your complete medication history, and adjust your treatment plan in time.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: